Mill Capital Management
TMO icon

Mill Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Mill Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$38M Buy
56,252
+98
+0.2% +$58.2K 2.49% 11
2026
Q2 		$28.2M Sell
56,154
-24,733
-31% -$11.9M 1.88% 17
2026
Q1 		$39.8M Buy
80,887
+61
+0.1% +$33.1K 3.02% 11
2025
Q4 		$46.8M Buy
80,826
+521
+0.6% +$295K 3.38% 7
2025
Q3 		$38.9M Buy
80,305
+792
+1% +$369K 2.89% 11
2025
Q2 		$32.2M Buy
79,513
+484
+0.6% +$202K 2.53% 13
2025
Q1 		$39.3M Buy
79,029
+251
+0.3% +$136K 3.15% 9
2024
Q4 		$41M Buy
78,778
+74
+0.1% +$40.7K 3.24% 8
2024
Q3 		$48.7M Buy
78,704
+444
+0.6% +$263K 3.81% 6
2024
Q2 		$43.3M Buy
78,260
+1,151
+1% +$659K 3.57% 6
2024
Q1 		$44.8M Buy
77,109
+298
+0.4% +$167K 3.74% 6
2023
Q4 		$40.8M Buy
76,811
+255
+0.3% +$123K 3.64% 6
2023
Q3 		$38.8M Sell
76,556
-41
-0.1% -$21.8K 3.79% 6
2023
Q2 		$40M Sell
76,597
-164
-0.2% -$88.5K 3.76% 6
2023
Q1 		$44.2M Sell
76,761
-9,701
-11% -$5.47M 4.49% 5
2022
Q4 		$47.6M Buy
86,462
+274
+0.3% +$145K 5.23% 4
2022
Q3 		$43.7M Buy
86,188
+368
+0.4% +$206K 5.1% 4
2022
Q2 		$46.6M Sell
85,820
-1,110
-1% -$611K 5.16% 4
2022
Q1 		$51.3M Buy
86,930
+8,975
+12% +$5.16M 4.91% 5
2021
Q4 		$52M Buy
+77,955
New +$48.7M 5.33% 5

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return
Loring Wolcott & Coolidge Fiduciary Advisors
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.8B AUM 9.05% 1-Year Est. Return
Lindsell Train
Lindsell Train London, United Kingdom $2.36B AUM 0.68% 1-Year Est. Return

Mill Capital Management's TMO Position: Q3 2026 in Review

Mill Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.17% in Q3 2026, buying an estimated $58.2K and bringing the position to 56,252 shares worth $38M. The position accounts for 2.49% of the portfolio, ranked #11.

Mill Capital Management first reported a position in TMO in Q4 2021 and has held it in 20 quarters since. The position peaked at $52M in Q4 2021. 1,189 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Mill Capital Management held 56,252 shares of Thermo Fisher Scientific worth $38M as of Q3 2026.
  • Mill Capital Management bought 98 Thermo Fisher Scientific shares in Q3 2026, an estimated $58.2K.
  • Thermo Fisher Scientific made up 2.49% of Mill Capital Management's portfolio in Q3 2026, its #11 holding.
  • Mill Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 20 quarters since.
  • Mill Capital Management's Thermo Fisher Scientific position peaked at $52M in Q4 2021.
  • 1,189 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.